Stockscreener 앱 받기
28.03
0.85%
-0.24
전일 마감가:
$28.27
열려 있는:
$28.59
하루 거래량:
695.61K
Relative Volume:
1.06
시가총액:
$1.46B
수익:
$1.08B
순이익/손실:
$-20.76M
주가수익비율:
-60.93
EPS:
-0.46
순현금흐름:
$151.63M
1주 성능:
-4.17%
1개월 성능:
-2.61%
6개월 성능:
-37.68%
1년 성능:
-0.81%
1일 변동 폭
$27.99
$28.62
1주일 범위
$27.99
$29.64
52주 변동 폭
$22.66
$55.74
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
OMCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
28.03 | 1.46B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
280.08 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
68.31 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
57.36 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
101.30 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.69 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Automated Medication Compounding System Market Generated - openPR.com
Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks - Yahoo Finance
Pharmacy Automation Devices Market Set to Witness Significant - openPR.com
Learn to Evaluate (OMCL) using the Charts - news.stocktradersdaily.com
Robotic Pharmacy Automation System Market Is Booming So Rapidly - openPR.com
Do Options Traders Know Something About Omnicell Stock We Don't? - The Globe and Mail
Omnicell Inc. to Pay $4.3 Million to Settle VA Overbilling Allegations - USA Herald
VA Contractor To Pay $4.3M To Resolve Overbilling Claims - Law360
Unit Dose Drug Delivery Systems Market Booming with Hospital Safety Initiatives | Omnicell Inc., Baxter International - openPR.com
New Technology Developments in Robotic Dispensing System - openPR.com
Omnicell Deploys Healthcare Automation to Ease Staff Strain and Elevate Patient Care - MarketScale
Omnicell Tackles Medication Inefficiency with RFID, AI, and a Vision for the Autonomous Pharmacy - MarketScale
Self-service Pharmacies Market Growth Expected to See Next Level | MedAvail, Omnicell, BD Rowa - openPR.com
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? - The Globe and Mail
omnicell announces cfo transition with separation agreement - Investing.com
omnicell announces cfo transition with separation agreement By Investing.com - Investing.com India
Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Adherence Packaging Market 2025- 2032 Overview: Share, Size, - openPR.com
OMCL: Upcoming Analyst Meetings Could Influence Stock Performanc - GuruFocus
OMCL: Upcoming Analyst Meetings Could Influence Stock Performance | OMCL Stock News - GuruFocus
Pharmacy Automation Market Overall Study Report 2025-2032 | - openPR.com
High Volume Dispensing Systems Market Report: Insights, - openPR.com
Two Sigma Advisers LP Sells 2,600 Shares of Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell opens innovation lab in Texas - MSN
Central Fill Pharmacy Automation Market Top Companies Study -Omnicell, Inc., McKesson Corporation, ScriptPro LLC - openPR.com
Pharmacy Automation Market in 2025-2032 Detailed Study - openPR.com
Opportunities for the Global Medication Management Solutions - openPR.com
BNP Paribas Financial Markets Lowers Position in Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell, Inc. (NASDAQ:OMCL) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Ameriprise Financial Inc. Trims Stake in Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell stock holds $40 target amid tariff cuts By Investing.com - Investing.com Nigeria
Omnicell stockholders approve equity plan amendment - Investing.com Australia
Omnicell stock rises on prospects of improved profitability due to U.S.-China trade truce, buyback - MSN
Omnicell stockholders approve equity plan amendment By Investing.com - Investing.com Nigeria
Omnicell Raises Earnings Forecast Amid Lower China Tariffs - Finimize
Omnicell Stockholders Approve Key Proposals at Annual Meeting - TipRanks
What Analysts Are Saying About Omnicell Stock - Benzinga
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | - GuruFocus
Omnicell (OMCL): Wells Fargo Raises Price Target to $37, Maintains Overweight Rating | OMCL Stock News - GuruFocus
Omnicell (OMCL): B of A Securities Raises Price Target to $34 | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stoc - GuruFocus
Piper Sandler Adjusts Omnicell Price Target to $57 From $46, Maintains Overweight Rating - marketscreener.com
Omnicell (OMCL) Target Price Raised by Piper Sandler | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback N - GuruFocus
Wells Fargo Boosts Price Target for Omnicell (OMCL) Amid Improved Outlook | OMCL Stock News - GuruFocus
Omnicell (OMCL) Target Price Increased Following Share Buyback News | OMCL Stock News - GuruFocus
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
옴니셀 주식 (OMCL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
2.80%
0.18%
자본화:
|
볼륨(24시간):